These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 19720557

  • 1. Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells.
    Kok SH, Yeh CC, Chen ML, Kuo MY.
    Oral Oncol; 2009 Dec; 45(12):1067-72. PubMed ID: 19720557
    [Abstract] [Full Text] [Related]

  • 2. Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression.
    Yeh CC, Deng YT, Sha DY, Hsiao M, Kuo MY.
    Mol Cancer Ther; 2009 Sep; 8(9):2718-25. PubMed ID: 19737941
    [Abstract] [Full Text] [Related]

  • 3. Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts.
    Yeh CC, Ko HH, Hsieh YP, Wu KJ, Kuo MY, Deng YT.
    Clin Oral Investig; 2016 Dec; 20(9):2343-2352. PubMed ID: 26822174
    [Abstract] [Full Text] [Related]

  • 4. Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK.
    Park C, Jin CY, Kim GY, Choi IW, Kwon TK, Choi BT, Lee SJ, Lee WH, Choi YH.
    Toxicol Appl Pharmacol; 2008 Mar 01; 227(2):219-28. PubMed ID: 18031783
    [Abstract] [Full Text] [Related]

  • 5. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 6. Inostamycin enhanced TRAIL-induced apoptosis through DR5 upregulation on the cell surface.
    Yamamoto K, Makino M, Watanapokasin R, Tashiro E, Imoto M.
    J Antibiot (Tokyo); 2012 Jun 15; 65(6):295-300. PubMed ID: 22472572
    [Abstract] [Full Text] [Related]

  • 7. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

  • 8. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells].
    Tong HX, Zhang JH, Ma L, Lu CW, Zhang JH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug 15; 8(4):327-30. PubMed ID: 16923369
    [Abstract] [Full Text] [Related]

  • 9. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF, Cao JG, Tian L, Liu F.
    Cancer Chemother Pharmacol; 2012 Jan 15; 69(1):195-206. PubMed ID: 21660448
    [Abstract] [Full Text] [Related]

  • 10. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X, Yue P, Zhou Z, Khuri FR, Sun SY.
    J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759
    [Abstract] [Full Text] [Related]

  • 11. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
    Yang J, Chen SZ.
    Yao Xue Xue Bao; 2010 Oct 01; 45(10):1247-53. PubMed ID: 21348302
    [Abstract] [Full Text] [Related]

  • 12. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 01; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells.
    Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T.
    Oncogene; 2004 Aug 19; 23(37):6261-71. PubMed ID: 15208660
    [Abstract] [Full Text] [Related]

  • 14. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 15. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN.
    Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279
    [Abstract] [Full Text] [Related]

  • 16. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY.
    Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429
    [Abstract] [Full Text] [Related]

  • 17. Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism.
    Rubio V, Calviño E, García-Pérez A, Herráez A, Diez JC.
    Chem Biol Interact; 2014 Sep 05; 220():129-39. PubMed ID: 24995577
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.
    Vondálová Blanárová O, Jelínková I, Szöor A, Skender B, Soucek K, Horváth V, Vaculová A, Andera L, Sova P, Szöllosi J, Hofmanová J, Vereb G, Kozubík A.
    Carcinogenesis; 2011 Jan 05; 32(1):42-51. PubMed ID: 21037225
    [Abstract] [Full Text] [Related]

  • 19. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
    Park MH, Jo M, Won D, Song HS, Song MJ, Hong JT.
    Apoptosis; 2012 Dec 05; 17(12):1316-26. PubMed ID: 23007278
    [Abstract] [Full Text] [Related]

  • 20. Combination of IFNγ and chemotherapeutic agents increase TRAIL sensitivity of neuroblastoma cell lines.
    Tong HX, Lu CW, Wang QS, Ma LY.
    Eur J Pediatr Surg; 2011 Oct 05; 21(5):304-9. PubMed ID: 21751122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.